Overcoming challenges of imaging in oligometastatic prostate cancer
Update on Study 19 trial of olaparib in serous ovarian cancer
Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway
What's next in melanoma research on drug resistance?
Treating ex-patients: beyond the 5-year follow-up